BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lohia S, Vlahou A, Zoidakis J. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective. Toxins 2022;14:176. [DOI: 10.3390/toxins14030176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Krukowski H, Valkenburg S, Madella AM, Garssen J, van Bergenhenegouwen J, Overbeek SA, Huys GRB, Raes J, Glorieux G. Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential. Nat Rev Nephrol 2023;19:87-101. [PMID: 36357577 DOI: 10.1038/s41581-022-00647-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sun X, Sun W, Huang Y, Chen J. Traditional Chinese Medicine: An Exogenous Regulator of Crosstalk between the Gut Microbial Ecosystem and CKD. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-15. [DOI: 10.1155/2022/7940684] [Reference Citation Analysis]
3 Ruszkowski J, Majkutewicz K, Heleniak Z, Witkowski JM, Dębska-ślizień A. Prevalence and Severity of Lower Gastrointestinal Symptoms amongst Non-Dialysis Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. JCM 2022;11:6363. [DOI: 10.3390/jcm11216363] [Reference Citation Analysis]